Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yangbowen Wu"'
Autor:
Shiwen Liu, Zhishi Deng, Jianxiong Li, Long Zou, Xiuhui Sun, Xiaoqing Liu, Yong Shi, Shunqiang Huang, Yangbowen Wu, Jinhui Lei, Peipei Liu, Pei Zhang, Ying Xiong, Zhong-Er Long
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 18, Iss 9, p e0012439 (2024)
BackgroundHemorrhagic fever with renal syndrome (HFRS) is a severe public health problem in Jiangxi province, China. Previous studies reported genetic variants of Orthohantavirus hantanense (Hantaan virus, HTNV) in rodents in this area. However, the
Externí odkaz:
https://doaj.org/article/8318e02e932142e9bfc0a60ebccedd38
Autor:
Xiangling Feng, Jiaojiao Guo, Gang An, Yangbowen Wu, Zhenhao Liu, Bin Meng, Nihan He, Xinying Zhao, Shilian Chen, Yinghong Zhu, Jiliang Xia, Xin Li, Zhiyong Yu, Ruixuan Li, Guofeng Ren, Jihua Chen, Minghua Wu, Yanjuan He, Lugui Qiu, Jiaxi Zhou, Wen Zhou
Publikováno v:
Advanced Science, Vol 9, Iss 9, Pp n/a-n/a (2022)
Abstract It has been previously shown that (never in mitosis gene A)‐related kinase 2 (NEK2) is upregulated in multiple myeloma (MM) and contributes to drug resistance. However, the mechanisms behind this upregulation remain poorly understood. In t
Externí odkaz:
https://doaj.org/article/7c7949c394ef451aadd0b6e77d819754
Autor:
Jiliang Xia, Yanjuan He, Bin Meng, Shilian Chen, Jingyu Zhang, Xuan Wu, Yinghong Zhu, Yi Shen, Xiangling Feng, Yongjun Guan, Chunmei Kuang, Jiaojiao Guo, Qian Lei, Yangbowen Wu, Gang An, Guancheng Li, Lugui Qiu, Fenghuang Zhan, Wen Zhou
Publikováno v:
Molecular Oncology, Vol 14, Iss 4, Pp 763-778 (2020)
NEK2 is associated with drug resistance in multiple cancers. Our previous studies indicated that high NEK2 confers inferior survival in multiple myeloma (MM); thus, a better understanding of the mechanisms by which NEK2 induces drug resistance in MM
Externí odkaz:
https://doaj.org/article/40ca287c80a94d59b45c6f39103fa18a
Autor:
Jiaojiao Guo, Xuan Wu, Shilian Chen, Chunmei Kuang, Gang An, Bin Meng, Jingyu Zhang, Yi Shen, Wen Zhou, Fenghuang Zhan, Yongjun Guan, Yinghong Zhu, Lugui Qiu, Jiliang Xia, Yanjuan He, Xiangling Feng, Guancheng Li, Yangbowen Wu, Qian Lei
Publikováno v:
Molecular Oncology, Vol 14, Iss 4, Pp 763-778 (2020)
Molecular Oncology
Molecular Oncology
NEK2 is associated with drug resistance in multiple cancers. Our previous studies indicated that high NEK2 confers inferior survival in multiple myeloma (MM); thus, a better understanding of the mechanisms by which NEK2 induces drug resistance in MM
Autor:
Yan Xu, Bin Meng, Dehui Zou, Lugui Qiu, Qian Lei, Meirong Zang, Minghua Wu, Yangbowen Wu, Jiaojiao Guo, Yinghong Zhu, Xiangling Feng, Gang An, Shuhui Deng, Wen Zhou, Yongjun Guan, Lanting Liu, Mu Hao, Xiaoqi Qin, Fengyan Jin
Publikováno v:
Oncogenesis
Oncogenesis, Vol 9, Iss 3, Pp 1-13 (2020)
Oncogenesis, Vol 9, Iss 3, Pp 1-13 (2020)
Multiple myeloma (MM) is the second most prevalent hematologic malignancy. Although the use of bortezomib (BTZ) significantly improves MM therapy, intrinsic and acquired drug resistance to BTZ remains a major clinical problem. In this study, we find
Autor:
Chunmei Kuang, Chen Shi, Yinghong Zhu, Liang Zeng, Songqing Fan, Shilian Chen, Jian Ouyang, Weihong Jiang, Xin Zhang, Jiaojiao Guo, Wen Zhou, Xuan Wu, Jiliang Xia, Guizhu Liu, Yongjun Guan, Xingxing Jian, Yangbowen Wu
Publikováno v:
Molecular Carcinogenesis
Nasopharyngeal carcinoma (NPC) has the highest rate of metastasis among head and neck cancers, and distant metastasis is the major reason for treatment failure. We have previously shown that high cyclooxygenase‐2 (COX‐2) expression is associated